<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4668">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04370067</url>
  </required_header>
  <id_info>
    <org_study_id>H-UNCOVER</org_study_id>
    <nct_id>NCT04370067</nct_id>
  </id_info>
  <brief_title>HUNgarian COronaVirus Disease-19 Epidemiological Research</brief_title>
  <official_title>Hungarian CoronaVirus Disease-19 Epidemiological Research</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University Heart and Vascular Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Semmelweis University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Szeged University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pecs</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Debrecen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Semmelweis University Heart and Vascular Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hungarian CoronaVirus disease-19 Epidemiological Research&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The planned large-scale, cross-sectional, representative population screening can show the&#xD;
      prevalence of COVID-19 and the degree of infection and trans-infection in Hungary after more&#xD;
      than one month of strict restriction. In addition, it can have an impact on further actions,&#xD;
      and we can track the impact of the decisions we make by repeating the screenings.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>COVID-19 rate</measure>
    <time_frame>1 year</time_frame>
    <description>The rate of the infected patients, asymptomatic carrier and healed patients</description>
  </primary_outcome>
  <enrollment type="Anticipated">11200</enrollment>
  <condition>Coronavirus Infection</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Hungarian male or female patients aged 14 and over who live in private households.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Hungarian male or female patients aged 14 and over who live in private households&#xD;
&#xD;
          -  Inactivated social security number does not infer the exclusion of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under the age of 14&#xD;
&#xD;
          -  Patients living in institutional households&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Béla Merkely, PhD,DSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Semmelweis University Heart and Vascular Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Béla Merkely, PhD,DSc</last_name>
    <phone>+36 20 825 8000</phone>
    <email>rektor@semmelweis-univ.hu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Annamaria Kosztin, MD,PhD</last_name>
    <phone>+ 36 20 666 3236</phone>
    <email>kosztin.annamaria@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Semmelweis University - Heart and Vascular Center</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Béla Merkely, PhD,DSc</last_name>
      <phone>+36 20 825 8000</phone>
      <email>rektor@semmelweis-univ.hu</email>
    </contact>
    <contact_backup>
      <last_name>Annamaria Kosztin, MD,PhD</last_name>
      <phone>+ 36 20 666 3236</phone>
      <email>kosztin.annamaria@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Debrecen</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ervin László Berényi, MD,PhD</last_name>
      <email>ervin.berenyi@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pecs</name>
      <address>
        <city>Pecs</city>
        <zip>7622</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andor Sebestyén, MD,PhD</last_name>
      <email>sebestyen.andor@pte.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Szeged</name>
      <address>
        <city>Szeged</city>
        <zip>6720</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Csaba Lengyel, MD,PhD</last_name>
      <phone>+36-62-545-186</phone>
      <email>lecs.in1st@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 28, 2020</study_first_submitted>
  <study_first_submitted_qc>April 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2020</study_first_posted>
  <last_update_submitted>June 11, 2020</last_update_submitted>
  <last_update_submitted_qc>June 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronavirus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

